NEXGEL, Inc. will announce first quarter 2025 financial results on May 13, followed by a conference call at 4:30 PM ET.
Quiver AI Summary
NEXGEL, Inc. will announce its financial results for the first quarter of 2025 on May 13, after the market closes. Following the announcement, the Company will hold a conference call at 4:30 PM ET, with participation options available via phone or webcast. A replay of the call will be accessible until May 27, 2025. NEXGEL specializes in ultra-gentle, high-water-content hydrogel products for healthcare and consumer use and has been a leader in this field for over two decades. The Company is based in Langhorne, Pennsylvania, and offers a range of brands including Silverseal® and Hexagels®, among others.
Potential Positives
- The scheduled conference call for financial results demonstrates NEXGEL's commitment to transparency and communication with investors.
- The announcement of financial results reporting indicates the company is actively managing its financial disclosures, which can bolster investor confidence.
- NEXGEL's established presence in the healthcare and consumer applications market highlights its potential for growth and market relevance.
- The availability of a webcast and replay options for the conference call showcases the company’s efforts to engage with a broader audience, ensuring accessibility to important information.
Potential Negatives
- The press release does not provide any preliminary insights or expectations regarding its upcoming financial results, which may lead to investor uncertainty.
- There is a lack of information regarding potential challenges or risks facing the company, which could leave investors feeling uninformed about the company's current situation.
- As the press release only outlines the timing of the financial results and the conference call, it may not adequately engage stakeholders who seek more substantive updates on company performance or strategy.
FAQ
What date will NEXGEL report its first quarter 2025 financial results?
NEXGEL will report its first quarter 2025 financial results on May 13, 2025.
What time is the NEXGEL conference call scheduled for?
The conference call is scheduled for 4:30 P.M. ET on May 13, 2025.
How can I join the NEXGEL conference call?
You can join the call by calling 1-800-343-4849 (U.S. toll-free) or 1-203-518-9848 (international).
Will there be a replay of the NEXGEL conference call?
Yes, a replay will be available until May 27, 2025, by calling +1-844-512-2921 (U.S. toll-free).
What products does NEXGEL specialize in?
NEXGEL specializes in ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$NXGL Insider Trading Activity
$NXGL insiders have traded $NXGL stock on the open market 15 times in the past 6 months. Of those trades, 6 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $NXGL stock by insiders over the last 6 months:
- ADAM R. LEVY (Chief Executive Officer) has made 1 purchase buying 3,636 shares for an estimated $9,999 and 4 sales selling 16,000 shares for an estimated $55,062.
- SCOTT ROBERT HENRY has made 1 purchase buying 1,818 shares for an estimated $4,999 and 5 sales selling 15,000 shares for an estimated $50,275.
- ADAM E III DRAPCZUK (Chief Financial Officer) purchased 17,500 shares for an estimated $48,125
- STEVEN MARK GLASSMAN purchased 9,090 shares for an estimated $24,997
- JOHN NACHUM STEIN purchased 3,636 shares for an estimated $9,999
- JEROME B ZELDIS purchased 3,636 shares for an estimated $9,999
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NXGL Hedge Fund Activity
We have seen 10 institutional investors add shares of $NXGL stock to their portfolio, and 4 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RENAISSANCE TECHNOLOGIES LLC added 129,876 shares (+456.4%) to their portfolio in Q4 2024, for an estimated $579,246
- MORGAN STANLEY added 86,204 shares (+5387.8%) to their portfolio in Q4 2024, for an estimated $384,469
- ESSEX INVESTMENT MANAGEMENT CO LLC added 38,459 shares (+inf%) to their portfolio in Q1 2025, for an estimated $114,607
- NORTHEAST FINANCIAL GROUP, INC. removed 31,848 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $142,042
- STATE STREET CORP added 17,259 shares (+inf%) to their portfolio in Q4 2024, for an estimated $76,975
- TWO SIGMA SECURITIES, LLC added 12,035 shares (+inf%) to their portfolio in Q4 2024, for an estimated $53,676
- IFP ADVISORS, INC added 11,000 shares (+100.0%) to their portfolio in Q1 2025, for an estimated $32,780
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
Management will host a conference call at 4:30 P.M. ET on the same day
LANGHORNE, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it will report its financial results for the first quarter 2025, after the market close on May 13, 2025. Following the release of its financial results, the Company will host a conference call at 4:30 p.m. ET on the same day.
First Quarter 2025 Financial Results Conference Call
Date:
May 13, 2025
Time:
4:30 P.M. ET
Live Call:
1-800-343-4849 (U.S. Toll Free) or 1-203-518-9848 (International)
Webcast:
Events and Presentations
For interested individuals unable to join the conference call, a replay will be available through May 27, 2025, by dialing + 1-844-512-2921 (U.S. Toll Free) or + 1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 11159118. An archived version of the webcast will also be available for 90 days.
About NEXGEL, INC.
NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include Silverseal ® , Hexagels ® , Turfguard ® , Kenkoderm ® and Silly George ® . Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.
Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
[email protected]
